{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "10472319", "DateCompleted": {"Year": "1999", "Month": "09", "Day": "22"}, "DateRevised": {"Year": "2019", "Month": "05", "Day": "03"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1351-0711", "JournalIssue": {"Volume": "56", "Issue": "7", "PubDate": {"Year": "1999", "Month": "Jul"}}, "Title": "Occupational and environmental medicine", "ISOAbbreviation": "Occup Environ Med"}, "ArticleTitle": "Compromised concentrations of ascorbate in fluid lining the respiratory tract in human subjects after exposure to ozone.", "Pagination": {"StartPage": "473", "EndPage": "481", "MedlinePgn": "473-81"}, "Abstract": {"AbstractText": ["Ozone (O3) imposes an oxidative burden on the lung in two ways. Firstly, directly as a consequence of its oxidising character during exposure, and secondly, indirectly by engendering inflammation. In this study the second pathway was considered by ascertaining the impact of O3 on the redox state of the fluid lining the respiratory tract 6 hours after challenge.", "Nine subjects were exposed in a double blind crossover control trial to air and 200 ppb O3 for 2 hours with an intermittent exercise and rest protocol. Blood samples were obtained and lung function (forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1)) assessed before, immediately after, and 6 hours after exposure. Bronchoalveolar lavage (BAL) was performed 6 hours after challenge. Inflammation was assessed in BAL fluid (total and differential cell counts, plus myeloperoxidase concentrations), and plasma and BAL fluid redox state were determined by measuring concentrations of antioxidants and markers of oxidative damage.", "Neutrophil numbers in BAL fluid increased 2.2-fold (p = 0.07) 6 hours after exposure and this was accompanied by increased myeloperoxidase concentrations in BAL fluid (p = 0.08). On the other hand, BAL fluid macrophage and lymphocyte numbers decreased 2.5-fold (p = 0.08) and 3.1-fold (p = 0.08), respectively at this time. Of the antioxidants examined, only ascorbate in BAL fluid was affected by O3, falling in all subjects relative to air values (0.1 (0.0-0.3) v 0.3 (0.2-1.2) mumol/l (p = 0.008)). A marginal decrease in plasma ascorbate was also detected at this time (p < 0.05). Although the decrease in macrophage numbers seemed to be causally related to the increase in neutrophils (R = -0.79), myeloperoxidase concentrations (R = -0.93) and ascorbate concentrations (R = 0.6), no clear associations were apparent between ascorbate changes and neutrophils or myeloperoxidase concentration after O3.", "Ascorbate in the fluid lining the respiratory tract is depleted as a consequence of O3 exposure at 6 hours after exposure. This was contemporaneous with, although not quantitatively related to the increase in neutrophil numbers and myeloperoxidase concentrations. Decreased macrophage numbers 6 hours after O3 related to the degree of neutrophilic inflammation with populations conserved where ascorbate concentration in the fluid lining the respiratory tract were high after exposure. These results imply that ascorbate has a critical protective role against inflammatory oxidative stress induced by O3."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Rayne Institute, St Thomas' Hospital, London, UK."}], "Identifier": [], "LastName": "Mudway", "ForeName": "I S", "Initials": "IS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Krishna", "ForeName": "M T", "Initials": "MT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Frew", "ForeName": "A J", "Initials": "AJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "MacLeod", "ForeName": "D", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sandstrom", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Holgate", "ForeName": "S T", "Initials": "ST"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kelly", "ForeName": "F J", "Initials": "FJ"}], "PublicationTypeList": ["Clinical Trial", "Controlled Clinical Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Occup Environ Med", "NlmUniqueID": "9422759", "ISSNLinking": "1351-0711"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "PQ6CK8PD0R", "NameOfSubstance": "Ascorbic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["analysis"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["analysis"], "DescriptorName": "Ascorbic Acid"}, {"QualifierName": ["chemistry", "cytology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Count"}, {"QualifierName": [], "DescriptorName": "Cross-Over Studies"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Forced Expiratory Volume"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Pneumonia"}, {"QualifierName": ["drug effects"], "DescriptorName": "Vital Capacity"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Am J Clin Nutr. 1979 Oct;32(10):2143-9", "ArticleIdList": ["484533"]}, {"Citation": "Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1700-5", "ArticleIdList": ["8970358"]}, {"Citation": "Anal Biochem. 1985 Oct;150(1):76-85", "ArticleIdList": ["3843705"]}, {"Citation": "Biochem Biophys Res Commun. 1985 Dec 17;133(2):773-9", "ArticleIdList": ["4084297"]}, {"Citation": "J Am Coll Nutr. 1986;5(3):305-12", "ArticleIdList": ["3734276"]}, {"Citation": "Biochim Biophys Acta. 1987 Jun 22;924(3):408-19", "ArticleIdList": ["3593759"]}, {"Citation": "Toxicology. 1990 Jan-Feb;60(1-2):15-25", "ArticleIdList": ["2315937"]}, {"Citation": "J Lab Clin Med. 1990 Apr;115(4):396-404", "ArticleIdList": ["2324609"]}, {"Citation": "Free Radic Biol Med. 1990;9(3):235-43", "ArticleIdList": ["2272532"]}, {"Citation": "Anal Biochem. 1990 Nov 1;190(2):360-5", "ArticleIdList": ["2291479"]}, {"Citation": "Am Rev Respir Dis. 1991 Jun;143(6):1353-8", "ArticleIdList": ["2048824"]}, {"Citation": "Biochem J. 1991 Jul 1;277 ( Pt 1):133-8", "ArticleIdList": ["1854329"]}, {"Citation": "Am J Clin Nutr. 1991 Dec;54(6 Suppl):1113S-1118S", "ArticleIdList": ["1962556"]}, {"Citation": "Nature. 1993 Jul 1;364(6432):79-82", "ArticleIdList": ["8316303"]}, {"Citation": "Exp Lung Res. 1993 Jul-Aug;19(4):469-84", "ArticleIdList": ["8370346"]}, {"Citation": "J Lab Clin Med. 1993 Nov;122(5):483-6", "ArticleIdList": ["8228563"]}, {"Citation": "Am Rev Respir Dis. 1993 Nov;148(5):1363-72", "ArticleIdList": ["8239177"]}, {"Citation": "Toxicol Appl Pharmacol. 1994 Mar;125(1):77-89", "ArticleIdList": ["8128499"]}, {"Citation": "Methods Enzymol. 1994;233:314-8", "ArticleIdList": ["8015465"]}, {"Citation": "Methods Enzymol. 1994;233:357-63", "ArticleIdList": ["8015470"]}, {"Citation": "Free Radic Biol Med. 1994 Nov;17(5):451-65", "ArticleIdList": ["7835752"]}, {"Citation": "Toxicol Appl Pharmacol. 1995 May;132(1):122-30", "ArticleIdList": ["7747275"]}, {"Citation": "Free Radic Biol Med. 1995 Dec;19(6):935-41", "ArticleIdList": ["8582671"]}, {"Citation": "Am J Respir Crit Care Med. 1996 Jan;153(1):3-50", "ArticleIdList": ["8542133"]}, {"Citation": "Respir Med. 1995 Nov;89(10):647-56", "ArticleIdList": ["8570878"]}, {"Citation": "Free Radic Res. 1996 Dec;25(6):499-513", "ArticleIdList": ["8951423"]}, {"Citation": "Fundam Appl Toxicol. 1996 May;31(1):56-64", "ArticleIdList": ["8998953"]}, {"Citation": "Anal Biochem. 1984 Aug 15;141(1):238-43", "ArticleIdList": ["6496931"]}]}], "History": [{"Year": "1999", "Month": "9", "Day": "3"}, {"Year": "1999", "Month": "9", "Day": "3", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "9", "Day": "3", "Hour": "0", "Minute": "0"}, {"Year": "2002", "Month": "7", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10472319", "PMC1757764", "10.1136/oem.56.7.473"]}}], "PubmedBookArticle": []}